Literature DB >> 24671018

Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension.

Masanari Kuwabara1, Koichiro Niwa2, Yutaro Nishi2, Atsushi Mizuno2, Taku Asano2, Keita Masuda2, Ikki Komatsu2, Masahiro Yamazoe2, Osamu Takahashi3, Ichiro Hisatome4.   

Abstract

The cause and effect relationship between serum uric acid levels and hypertension can be difficult to evaluate because antihypertensive drugs sometimes affect uric acid levels. This cross-sectional study investigated the relationship between serum uric acid levels and hypertension in a general, healthy Japanese population who were not receiving medication for hyperuricemia or hypertension. We retrospectively analyzed the medical records of 90 143 Japanese people (men, 49.1%; age, 46.3±12.0 years) undergoing an annual medical examination at St Luke's International Hospital Center for Preventive Medicine, Tokyo, between January 2004 and June 2010. Of these individuals, 82 722 (91.8%) who had never taken medications for gout, hyperuricemia or hypertension were enrolled. We compared the participant characteristics and prevalence of diastolic hypertension (⩾90 mm Hg) and/or systolic hypertension (⩾140 mm Hg) by serum uric acid quartile. The odds ratio (OR) of hypertension was 1.20 for each 1 mg dl(-1) increase in serum uric acid level after adjustment for age, sex, body mass index (BMI), dyslipidemia, diabetes, smoking and estimated glomerular filtration rate (eGFR). Compared with the lowest serum uric acid quartile, participants in the highest quartile had a 3.7-fold higher OR for hypertension. After adjustment for age, BMI, dyslipidemia, diabetes, smoking and eGFR, these ORs were 1.79 (1.62-1.98) in the total study population, 1.58 (1.44-1.75) in men and 1.60 (1.39-1.84) in women. The results were similar for both systolic and diastolic hypertension. Elevated serum uric acid levels may be as important as obesity, dyslipidemia, diabetes, smoking and reduced kidney function for the development of hypertension and should be considered in hypertension prevention programs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24671018     DOI: 10.1038/hr.2014.75

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  40 in total

1.  Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample.

Authors:  Yunkyung Kim; Jihun Kang; Geun-Tae Kim
Journal:  Clin Rheumatol       Date:  2018-05-23       Impact factor: 2.980

2.  Effects of uric-acid-lowering therapy on renal outcomes: the future looks promising.

Authors:  Vassilis Filiopoulos
Journal:  Hypertens Res       Date:  2016-05-19       Impact factor: 3.872

3.  Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function.

Authors:  Masanari Kuwabara; Petter Bjornstad; Ichiro Hisatome; Koichiro Niwa; Carlos A Roncal-Jimenez; Ana Andres-Hernando; Thomas Jensen; Tamara Milagres; Yuka Sato; Gabriela Garcia; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson
Journal:  Am J Nephrol       Date:  2017-03-11       Impact factor: 3.754

4.  "Metabolically Healthy" Obesity and Hyperuricemia Increase Risk for Hypertension and Diabetes: 5-year Japanese Cohort Study.

Authors:  Masanari Kuwabara; Remi Kuwabara; Ichiro Hisatome; Koichiro Niwa; Carlos A Roncal-Jimenez; Petter Bjornstad; Ana Andres-Hernando; Yuka Sato; Thomas Jensen; Gabriela Garcia; Minoru Ohno; James O Hill; Miguel A Lanaspa; Richard J Johnson
Journal:  Obesity (Silver Spring)       Date:  2017-09-18       Impact factor: 5.002

5.  High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism.

Authors:  Miguel A Lanaspa; Masanari Kuwabara; Ana Andres-Hernando; Nanxing Li; Christina Cicerchi; Thomas Jensen; David J Orlicky; Carlos A Roncal-Jimenez; Takuji Ishimoto; Takahiko Nakagawa; Bernardo Rodriguez-Iturbe; Paul S MacLean; Richard J Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-05       Impact factor: 11.205

6.  The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis.

Authors:  Punnaka Pongpanich; Pasvich Pitakpaiboonkul; Kullaya Takkavatakarn; Kearkiat Praditpornsilpa; Somchai Eiam-Ong; Paweena Susantitaphong
Journal:  Int Urol Nephrol       Date:  2018-10-15       Impact factor: 2.370

7.  High rate of calories from protein is associated with higher prevalence of hypertension.

Authors:  Masanari Kuwabara; Koichiro Niwa; Minoru Ohno; Ichiro Hisatome
Journal:  J Hum Hypertens       Date:  2019-01-15       Impact factor: 3.012

Review 8.  Hyperuricemia, Cardiovascular Disease, and Hypertension.

Authors:  Masanari Kuwabara
Journal:  Pulse (Basel)       Date:  2016-03-12

Review 9.  Asymptomatic hyperuricemia: is it time to intervene?

Authors:  Binoy J Paul; K Anoopkumar; Vinod Krishnan
Journal:  Clin Rheumatol       Date:  2017-10-04       Impact factor: 2.980

10.  Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia.

Authors:  Kentaro Kohagura; Takeshi Tana; Akira Higa; Masanobu Yamazato; Akio Ishida; Kazufumi Nagahama; Atsushi Sakima; Kunitoshi Iseki; Yusuke Ohya
Journal:  Hypertens Res       Date:  2016-04-14       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.